Patient with COVID-19 in Delft On 29 February, a woman in Delft was diagnosed with the novel coronavirus (COVID-19) in the Netherlands. The woman had been in Lombardy, in Northern Italy, last week.
National Agreement leads to small improvement in intake of salt and sugar RIVM calculations show that only small steps have been taken to reduce daily salt and energy intake (via sugar) within the National Agreement to Improve Product Composition.
EFSA to use RIVM-model to assess the health risks of mixtures of plant protection products The European Food Safety Authority (EFSA) and RIVM are jointly conducting pilot assessments into the health risks posed to consumers through exposure to multiple pesticides via food.
PhD dissertation: Dutch Q fever epidemic in 'One Health' context Today Barbara Schimmer will be defending her PhD dissertation entitled The Q fever epidemic in the Netherlands in a One Health context, at Utrecht University.
Lyme disease cases have quadrupled According to a survey by RIVM , 27,000 people were infected with Lyme disease in 2017. In 2014, the last time RIVM reported on the incidence of tick-borne disease, this number was 25,000.
WHO:RIVM Centre for Healthy Living a good practice for other countries According to the World Health Organization (WHO), the RIVM Centre for Healthy Living is a prime example of how the national government has taken up its stewardship role within the health promo
ANSES and RIVM foster collaboration RIVM was delighted to welcome a delegation from ANSES (French Agency for Food, Environmental and Occupational Health & Safety) in Bilthoven on April 10th.
Exposure to Bisphenol A via food is very limited Calculations carried out by RIVM indicate that the total intake of Bisphenol A (BPA) via food in the Netherlands is very limited.
Climate change, ozone depletion and air quality need to be addressed coherently Ozone layer depletion, air pollution and climate change need to be addressed in connection with each other.
Oncology drugs are a target for pharmaceutical crime Oncology drugs clearly have become a target for pharmaceutical crime.